1. Home
  2. INZY vs UBFO Comparison

INZY vs UBFO Comparison

Compare INZY & UBFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INZY
  • UBFO
  • Stock Information
  • Founded
  • INZY 2015
  • UBFO 1987
  • Country
  • INZY United States
  • UBFO United States
  • Employees
  • INZY N/A
  • UBFO N/A
  • Industry
  • INZY Biotechnology: Pharmaceutical Preparations
  • UBFO Major Banks
  • Sector
  • INZY Health Care
  • UBFO Finance
  • Exchange
  • INZY Nasdaq
  • UBFO Nasdaq
  • Market Cap
  • INZY 165.1M
  • UBFO 170.4M
  • IPO Year
  • INZY 2020
  • UBFO N/A
  • Fundamental
  • Price
  • INZY $2.73
  • UBFO $10.00
  • Analyst Decision
  • INZY Strong Buy
  • UBFO
  • Analyst Count
  • INZY 7
  • UBFO 0
  • Target Price
  • INZY $16.14
  • UBFO N/A
  • AVG Volume (30 Days)
  • INZY 885.2K
  • UBFO 22.8K
  • Earning Date
  • INZY 11-05-2024
  • UBFO 01-23-2025
  • Dividend Yield
  • INZY N/A
  • UBFO 4.80%
  • EPS Growth
  • INZY N/A
  • UBFO N/A
  • EPS
  • INZY N/A
  • UBFO 1.03
  • Revenue
  • INZY N/A
  • UBFO $51,962,000.00
  • Revenue This Year
  • INZY N/A
  • UBFO N/A
  • Revenue Next Year
  • INZY N/A
  • UBFO N/A
  • P/E Ratio
  • INZY N/A
  • UBFO $9.96
  • Revenue Growth
  • INZY N/A
  • UBFO N/A
  • 52 Week Low
  • INZY $2.39
  • UBFO $7.02
  • 52 Week High
  • INZY $7.80
  • UBFO $10.49
  • Technical
  • Relative Strength Index (RSI)
  • INZY 41.48
  • UBFO 59.80
  • Support Level
  • INZY $2.84
  • UBFO $9.70
  • Resistance Level
  • INZY $3.28
  • UBFO $10.38
  • Average True Range (ATR)
  • INZY 0.25
  • UBFO 0.20
  • MACD
  • INZY 0.10
  • UBFO -0.02
  • Stochastic Oscillator
  • INZY 48.84
  • UBFO 37.97

About INZY Inozyme Pharma Inc.

Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.

About UBFO United Security Bancshares

United Security Bancshares operates as the holding for United Security Bank. It provides commercial banking services to the business and professional community, and individuals located in Fresno, Madera, Santa Clara, and Kern Counties. It offers checking and savings accounts, deposits, mortgage loans, credit and debit cards, safe deposit boxes, automated teller machines, wire transfers, money market accounts, mobile banking, and wealth management services. The company's primary sources of revenue are interest income from loans and investment securities.

Share on Social Networks: